Hill-Rom Holdings, Inc. (HRC) Reaches $76.89 52-Week High, Biotime (NYSEMKT:BTX) Shorts Increased By 4.64% – UtahHerald.com

June 12, 2017 - By Hazel Jackson

The stock of Hill-Rom Holdings, Inc. (NYSE:HRC) hit a new 52-week high and has $80.73 target or 5.00% above todays $76.89 share price. The 7 months bullish chart indicates low risk for the $4.98 billion company. The 1-year high was reported on Jun, 12 by Barchart.com. If the $80.73 price target is reached, the company will be worth $249.00M more. About 21,379 shares traded. Hill-Rom Holdings, Inc. (NYSE:HRC) has risen 57.47% since June 12, 2016 and is uptrending. It has outperformed by 40.77% the S&P500.

Biotime Incorporated (NYSEMKT:BTX) had an increase of 4.64% in short interest. BTXs SI was 5.53M shares in June as released by FINRA. Its up 4.64% from 5.29M shares previously. With 237,800 avg volume, 23 days are for Biotime Incorporated (NYSEMKT:BTX)s short sellers to cover BTXs short positions. The SI to Biotime Incorporateds float is 8.6%. About 72,830 shares traded. BioTime, Inc. (NYSEMKT:BTX) has risen 22.71% since June 12, 2016 and is uptrending. It has outperformed by 6.01% the S&P500.

Analysts await Hill-Rom Holdings, Inc. (NYSE:HRC) to report earnings on August, 3. They expect $0.90 EPS, up 11.11% or $0.09 from last years $0.81 per share. HRCs profit will be $58.29M for 21.36 P/E if the $0.90 EPS becomes a reality. After $0.88 actual EPS reported by Hill-Rom Holdings, Inc. for the previous quarter, Wall Street now forecasts 2.27% EPS growth.

Hill-Rom Holdings, Inc. is a global medical technology company. The company has market cap of $4.98 billion. The Firm operates through four divisions: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. It has a 33.16 P/E ratio. The Companys services and products include Patient Support Systems, Front Line Care and Surgical Solutions.

Among 6 analysts covering Hill-Rom (NYSE:HRC), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Hill-Rom had 7 analyst reports since September 23, 2015 according to SRatingsIntel. The company was initiated on Wednesday, February 8 by Barclays Capital. The firm has Buy rating given on Tuesday, January 24 by Stifel Nicolaus. The rating was upgraded by Northcoast to Buy on Wednesday, December 16. The stock of Hill-Rom Holdings, Inc. (NYSE:HRC) has Buy rating given on Monday, May 1 by Stifel Nicolaus. The rating was reinitiated by Goldman Sachs with Neutral on Wednesday, September 23. The stock of Hill-Rom Holdings, Inc. (NYSE:HRC) earned Overweight rating by Morgan Stanley on Thursday, June 16. KeyBanc Capital Markets upgraded Hill-Rom Holdings, Inc. (NYSE:HRC) on Thursday, January 21 to Overweight rating.

Investors sentiment increased to 1.42 in 2016 Q4. Its up 0.04, from 1.38 in 2016Q3. It increased, as 34 investors sold Hill-Rom Holdings, Inc. shares while 72 reduced holdings. 45 funds opened positions while 105 raised stakes. 54.15 million shares or 0.55% more from 53.85 million shares in 2016Q3 were reported. Blackrock Group Ltd invested in 75,940 shares or 0% of the stock. Clarivest Asset Management Limited Com has invested 0.07% in Hill-Rom Holdings, Inc. (NYSE:HRC). Parametric Port Associates Limited Liability Com invested 0.02% in Hill-Rom Holdings, Inc. (NYSE:HRC). Retirement Systems Of Alabama stated it has 111,225 shares or 0.04% of all its holdings. Next Fin Gp has 50 shares. Johnson Investment Counsel Inc invested in 13,136 shares. Citigroup Inc reported 19,330 shares. Gargoyle Inv Advisor Lc accumulated 1.06% or 48,457 shares. Riverhead Cap Mngmt Limited Liability Company invested 0.01% in Hill-Rom Holdings, Inc. (NYSE:HRC). Serv Corp stated it has 0.01% in Hill-Rom Holdings, Inc. (NYSE:HRC). Hillsdale Invest Mngmt Inc has 0.05% invested in Hill-Rom Holdings, Inc. (NYSE:HRC) for 4,500 shares. Tiaa Cref Invest Mngmt Ltd reported 227,796 shares stake. The British Columbia Canada-based Pacad Inv has invested 0.06% in Hill-Rom Holdings, Inc. (NYSE:HRC). The New Jersey-based Blackrock Inv Ltd Limited Liability Company has invested 0.01% in Hill-Rom Holdings, Inc. (NYSE:HRC). Ahl Prtn Ltd Liability Partnership accumulated 0.11% or 65,280 shares.

Since February 9, 2017, it had 0 buys, and 6 selling transactions for $15.95 million activity. The insider Richardson Jason sold $143,124. Shares for $13.70M were sold by GREISCH JOHN J. SHADER ALTON also sold $1.04M worth of Hill-Rom Holdings, Inc. (NYSE:HRC) on Thursday, March 16. The insider Johnson Paul Sherwood sold 2,078 shares worth $150,239. Shares for $838,067 were sold by FRANK ANDREAS G on Tuesday, June 6.

BioTime, Inc. is a clinical-stage biotechnology firm focused on developing and commercializing products addressing degenerative diseases. The company has market cap of $349.23 million. The Companys clinical programs are based on two platform technologies: pluripotent stem cells and cell/drug delivery platform technologies. It has a 3.22 P/E ratio. The foundation of its cell delivery platform is its HyStem cell and drug delivery matrix technology.

Since February 15, 2017, it had 2 buys, and 0 sales for $6.01 million activity. 2,000 shares were bought by ANDREWS DEBORAH J, worth $6,410. Another trade for 2.22 million shares valued at $6.00 million was made by BROADWOOD PARTNERS L.P. on Wednesday, February 15.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Read the original:
Hill-Rom Holdings, Inc. (HRC) Reaches $76.89 52-Week High, Biotime (NYSEMKT:BTX) Shorts Increased By 4.64% - UtahHerald.com